Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Talis Biomedical Corp | 95,000 | reported | 09 Jun 2023 | tx 11+1,912,564−1,987,794 |
| Invitae Corp | 86,705 | reported | 27 Apr 2023 | tx 7+266,833 |
| BridgeBio Pharma, Inc. | 11,589 | reported | 15 May 2026 | tx 30+282,345−72,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 10,000 | 16.75 USD | 10b5-1 |
| 15 May 2026 | SALE | BridgeBio Pharma, Inc. | 6,200 | 66.69 USD | 10b5-1 |
| 15 May 2026 | SALE | BridgeBio Pharma, Inc. | 2,088 | 67.53 USD | 10b5-1 |
| 15 May 2026 | SALE | BridgeBio Pharma, Inc. | 1,512 | 68.23 USD | 10b5-1 |
| 15 May 2026 | SALE | BridgeBio Pharma, Inc. | 200 | 69.12 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | BridgeBio Pharma, Inc. | 10,000 | 0.00 USD | 10b5-1deriv |
| 17 Feb 2026 | EXERCISE | BridgeBio Pharma, Inc. | 10,000 | 16.75 USD | |
| 17 Feb 2026 | SALE | BridgeBio Pharma, Inc. | 1,900 | 74.34 USD | |
| 17 Feb 2026 | SALE | BridgeBio Pharma, Inc. | 4,793 | 75.57 USD | |
| 17 Feb 2026 | SALE | BridgeBio Pharma, Inc. | 3,307 | 75.93 USD | |
| 17 Feb 2026 | EXERCISE | BridgeBio Pharma, Inc. | 10,000 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | BridgeBio Pharma, Inc. | 10,000 | 16.75 USD | |
| 17 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 3,801 | 66.25 USD | |
| 17 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 6,199 | 66.89 USD | |
| 17 Nov 2025 | EXERCISE | BridgeBio Pharma, Inc. | 10,000 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 6,589 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 8,425 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 26,014 | 0.00 USD | deriv |
| 03 Jun 2024 | SALE | BridgeBio Pharma, Inc. | 200 | 29.48 USD | |
| 04 Jun 2024 | SALE | BridgeBio Pharma, Inc. | 1,500 | 31.30 USD | |
| 03 Jun 2024 | SALE | BridgeBio Pharma, Inc. | 800 | 28.68 USD | |
| 01 Mar 2024 | SALE | BridgeBio Pharma, Inc. | 2,500 | 34.00 USD | |
| 18 Dec 2023 | SALE | BridgeBio Pharma, Inc. | 2,000 | 40.00 USD | |
| 01 Dec 2023 | SALE | BridgeBio Pharma, Inc. | 1,000 | 28.50 USD | |
| 01 Dec 2023 | SALE | BridgeBio Pharma, Inc. | 1,500 | 30.00 USD |